You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
2型糖尿病患者におけるSGLT2阻害薬カナグリフロジン投与時の血中及び腎マグネシウム動態変動の意義
|
|---|---|
| Published in |
Journal of the Japan Diabetes Society, October 2017
|
| DOI | 10.11213/tonyobyo.60.700 |
| Authors |
古山 士津子, 菊池 健次郎, 大堀 克己 |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2020.
All research outputs
#21,049,824
of 25,852,155 outputs
Outputs from Journal of the Japan Diabetes Society
#139
of 173 outputs
Outputs of similar age
#265,067
of 341,261 outputs
Outputs of similar age from Journal of the Japan Diabetes Society
#2
of 2 outputs
Altmetric has tracked 25,852,155 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 173 research outputs from this source. They receive a mean Attention Score of 3.7. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,261 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.